Access our complete catalogue of cancer immunotherapy clinical practice guidelines using the SITC CPG Mobile App.
This fellowship award is named after Holbrook Kohrt, MD, PhD, assistant professor at the Stanford University School of Medicine, renowned for his clinical trials research examining novel immunologic approaches and his translational research on novel therapies to enhance anti-tumor immunity. Dr. Kohrt was a member of the Levy Laboratory, which helped develop and test the first U.S. Food and Drug Administration (FDA)-approved antibody against cancer for the treatment of lymphoma in 1997. He started his own laboratory in 2012, and helped develop five novel patented approaches to cancer immunotherapy
Made possible by an educational grant from Genentech.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org